Dyadic and Fermbox Bio Launch Animal-Origin-Free Recombinant DNase I, First Commercialized Product Under Expanded Collaboration.
ByAinvest
Wednesday, Mar 4, 2026 7:22 am ET1min read
DYAI--
Dyadic Applied BioSolutions and Fermbox Bio have launched their first commercial product, animal-origin-free Recombinant DNase I (RNase-free), under their expanded collaboration. This product is produced using Dyadic's high-yield fungal microbial expression platforms and Fermbox Bio's scale-up and biomanufacturing capabilities. Recombinant DNase I is used for nucleic-acid clean-up and sample preparation workflows, and is currently available in research grade with a cGMP-grade version in development.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet